Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
T7 RNA Polymerase for RNA Assay Workflows
2026-08-18
T7 RNA Polymerase enables defined, promoter-directed RNA production from linearized plasmids and PCR templates for probes, translation studies, RNAi, and vaccine research. This guide connects practical transcription control with the DDX21–NAT10 findings reported in colorectal cancer, while highlighting assay boundaries and troubleshooting strategies.
-
Gramine for Ferroptosis and TNBC Research
2026-08-18
Gramine is a research-grade ferroptosis inducer for connecting triple-negative breast cancer cell viability with CUL3–MTDH signaling. This practical guide covers solvent handling, dose-response design, target-engagement assays, rescue experiments, and troubleshooting for reproducible cancer biology research.
-
BHQ: Selective SERCA Inhibitor for Calcium Research
2026-08-17
2,5-di-tert-butylbenzene-1,4-diol (BHQ) is a selective SERCA inhibitor used to study endoplasmic reticulum calcium storage, calcium signaling, and cellular stress. A 2025 in vivo study linked BHQ-mediated SERCA inhibition with enhanced hematopoietic stem cell mobilization through the CaMKII-STAT3-CXCR4 pathway.
-
TH287 Radiosensitizes CRPC Cells to Ionizing Radiation
2026-08-17
The 2026 reference study identifies a schedule-dependent radiosensitizing effect of TH287 in PC-3 and DU-145 castration-resistant prostate cancer cells. Its central finding is that administering ionizing radiation 12 hours after MTH1 inhibition produced stronger survival suppression, apoptosis, and cell-cycle disruption than later radiation schedules.
-
AMG 9810: TRPV1 Antagonist Workflow Guide
2026-08-16
Build cleaner TRPV1 experiments with AMG 9810, from capsaicin-evoked calcium imaging to CGRP secretion assays. This guide combines practical dosing, solvent controls, metabolic-stress safeguards, and troubleshooting for pain mechanism research.
-
Benzyl Quinolone Carboxylic Acid (BQCA) Workflow
2026-08-15
Benzyl Quinolone Carboxylic Acid (BQCA) offers a selective way to amplify acetylcholine-driven M1 receptor signaling without relying on broad muscarinic activation. This workflow connects concentration–response assays, BRET coupling studies, neuronal readouts, and troubleshooting strategies for cognitive function modulation and Alzheimer’s disease research.
-
Lipo3K Transfection Reagent for Resistance Studies
2026-08-14
Use Lipo3K Transfection Reagent to build reproducible DNA, siRNA, mRNA, and co-transfection workflows in adherent, suspension, and difficult-to-transfect cells. Its low-toxicity profile and plasmid-focused Lipo3K-A enhancer are especially useful for testing transporter biology in paclitaxel-resistant breast cancer models.
-
β-Elemene: Applied 3T3-L1 Research Workflows
2026-08-14
Build a reproducible β-Elemene workflow for adipogenesis, insulin-resistance, and AMPK studies, while preserving clear boundaries between metabolic evidence and neuroprotective or anticancer hypotheses. The guide combines the published 3T3-L1 model with practical dosing, assay-selection, solubility, and troubleshooting strategies.
-
MK-8745: Translating Aurora A Biology to Oncology
2026-08-13
A translational perspective on how MK-8745, a potent and selective Aurora A inhibitor, can connect mitotic biology with cancer-model strategy. The article integrates recent retinoblastoma evidence, practical assay design, xenograft interpretation, and the limitations that matter when moving from target validation to therapeutic hypotheses.
-
N1-Methylpseudouridine: A Translational Strategy
2026-08-13
A mechanistic and strategic guide to using N1-Methylpseudouridine for more reliable mRNA translation studies, with lessons from PCMT1-driven ovarian cancer metastasis research.
-
Injectable GelMA/QCS/Ca2+ Adhesive for Hemostasis
2026-08-12
The reference study develops a blue-light-triggered GelMA/QCS/Ca2+ double-network adhesive for rapid control of non-compressible bleeding and bacterial wound protection. Its multi-model evaluation suggests that combining photochemical sealing, tissue adhesion, and chitosan-derived antibacterial activity may address limitations of single-function hemostatic materials.
-
From Ferrous Iron to Translational Insight
2026-08-12
FerroOrange, a Fe²⁺ fluorescent probe for live-cell ferrous ion detection, can help translational researchers connect intracellular iron dynamics with ferroptosis, microglial signaling, and neuronal injury. This thought-leadership guide uses recent Cdk5–AMPK evidence to define rigorous assay strategy, competitive positioning, and the limits of interpreting Fe²⁺ fluorescence.
-
AZ505: Reading SMYD2 Biology Through Assays
2026-08-11
AZ505 is a substrate-competitive SMYD2 inhibitor for dissecting methyltransferase-dependent signaling. This article translates biochemical selectivity and renal fibrosis evidence into a practical, phenotype-to-mechanism assay strategy for epigenetic regulation research and cancer biology research.
-
T7 RNA Polymerase for Translational RNA Biology
2026-08-11
A mechanism-first guide to using T7 RNA Polymerase for validating the HEY2–mitochondrial respiration axis, designing reproducible RNA workflows, and translating cardiovascular biology into controlled molecular assays.
-
Clozapine N-oxide: From Ligand to Circuit Evidence
2026-08-10
Clozapine N-oxide (CNO) is more than a DREADDs activator: it is a causal assay tool for linking engineered GPCR signaling to neuronal activity modulation. This article applies CNO-centered experimental logic to the dPAG GABAergic mechanisms studied in PMDD mice, with practical controls and formulation guidance.